Finance

Lists
301331:SHE
Enwei Pharmaceutical Co Ltd
CN¥20.66
+0.10%
(+0.020) 1D
Oct 19, 3:04:07 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301331...
Open
CN¥20.41
High
CN¥20.97
Low
CN¥20.02
Mkt. cap
2.12B
Avg. vol.
1.22M
Volume
1.42M
Dividend
4.99%
Quarterly dividend
CN¥0.26
Ex-dividend date
May 28, 2026
P/E ratio
75.27
52-wk high
CN¥33.50
52-wk low
CN¥18.87
EPS
CN¥0.27
Shares outstanding
102.89M
No. of employees
2K
Open
CN¥20.41
High
CN¥20.97
Low
CN¥20.02
Mkt. cap
2.12B
Avg. vol.
1.22M
Volume
1.42M
Dividend
4.99%
Quarterly dividend
CN¥0.26
Ex-dividend date
May 28, 2026
P/E ratio
75.27
52-wk high
CN¥33.50
52-wk low
CN¥18.87
EPS
CN¥0.27
Shares outstanding
102.89M
No. of employees
2K
News stories
From web sources and news partners
About Enwei Pharmaceutical Co Ltd
CEO-
Employees1.5K
Founded1986
Headquarters-
SectorPharmaceutical industry
Websiteenwei.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
187.63M
263.92M
175.33M
199.25M
Cost of goods sold
102.65M
123.62M
77.69M
105.31M
Cost of revenue
102.65M
123.62M
77.69M
105.31M
Research and development expenses
1.76M
1.22M
1.11M
1.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
91.00M
108.50M
82.73M
90.38M
Operating expense
93.18M
115.42M
85.17M
93.84M
Total operating expenses
195.83M
239.04M
162.86M
199.15M
Operating income
-8.20M
24.87M
12.47M
102.77K
Other non operating income
341.20K
-843.50K
-62.65K
-245.26K
EBT including unusual items
-2.54M
20.98M
13.88M
4.07M
EBT excluding unusual items
-6.27M
25.60M
13.52M
248.11K
Income tax expense
-782.36K
5.62M
1.38M
553.50K
Effective tax rate
30.78%
26.77%
9.93%
13.59%
Other operating expenses
2.36M
3.57M
1.89M
2.41M
Net income
-1.76M
15.36M
12.50M
3.52M
Net profit margin
-0.94%
5.82%
7.13%
1.77%
Earnings per share
-
-
-
-
Interest and investment income
2.19M
1.88M
1.69M
892.61K
Interest expense
-606.94K
-308.97K
-578.12K
-502.01K
Net interest expenses
1.59M
1.57M
1.11M
390.60K
Depreciation and amortization charges
-
-
-
-
EBITDA
3.02M
36.41M
24.01M
12.01M
Gain or loss from assets sale
-263.27K
138.01K
-
-2.69M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps